https://www.tga.gov.au/post-market-evaluation-serology-based-point-care-testsSARS-CoV-2 Antibody Test (Lateral Flow Method) (Guangzhou Wondfo Biotech Co Ltd, China)
The overall total antibody sensitivity and specificity claimed by the manufacturer in the IFU provided with the device is 86.43% and 99.57% respectively (note this device does not distinguish between IgM and IgG results).
The overall total antibody sensitivity of the device when tested by the Doherty Institute was found to be 68.6% while the total antibody specificity was found to be 97.8%. For samples collected 14 days post onset of symptoms the overall sensitivity improved to 93.8%.
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
